glucosamin-ratiopharm
ratiopharm gmbh - gliukozamino sulfatas - milteliai geriamajam tirpalui - 1,5 g - glucosamine
glucosamina kern pharma
limedika, uab - gliukozamino sulfatas - milteliai geriamajam tirpalui - 1500 mg - glucosamine
glucosamine pharma nord
pharma nord aps - gliukozaminas - kietosios kapsulės - 400 mg - glucosamine
glucosan
aconitum, uab - gliukozamino sulfatas - kietosios kapsulės - 750 mg - glucosamine
glycophos
fresenius kabi ab - natrio glicerofosfatas - koncentratas infuziniam tirpalui - 216 mg/ml - sodium glycerophosphate
glucosa 40%
limedika, uab - gliukozė - injekcinis tirpalas - 40 % - carbohydrates
remaid
sia ingen pharma - gliukozamino sulfatas - milteliai geriamajam tirpalui - 1,5 g - glucosamine
yescarta
kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antinavikiniai vaistai - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.
arthryl
viatris healthcare limited - gliukozamino sulfatas - milteliai geriamajam tirpalui - 750 mg; 1,5 g - glucosamine